Analysis of neurosterols by GC-MS and LC-MS/MS

被引:43
作者
Griffiths, William J. [1 ]
Wang, Yuqin [1 ]
机构
[1] Swansea Univ, Sch Med, Inst Mass Spectrometry, Swansea SA2 8PP, W Glam, Wales
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2009年 / 877卷 / 26期
基金
英国生物技术与生命科学研究理事会;
关键词
Sterol; Mass spectrometry; Lipidomics; Cholesterol; Alzheimer's disease; LXR; Brain; Oxysterol; TANDEM MASS-SPECTROMETRY; AMYLOID PRECURSOR PROTEIN; CHOLESTEROL-BIOSYNTHESIS PATHWAY; CHAIN OXIDIZED OXYSTEROLS; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; LIVER X RECEPTORS; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE;
D O I
10.1016/j.jchromb.2009.05.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The term neurosteroid was coined by Baulieu and colleagues in Paris towards the end of the last century to describe steroids which are synthesised in the central or peripheral nervous system [E.E. Baulieu, Psychoneuroendocrinology 23 (1998) 963-87]. This definition was restricted to side-chain "shortened" steroids with 21 carbon atoms or less, and excluded sterols and their carboxylic acids with an intact side-chain. By analogy, we now use the term neurosterol to describe C-27 sterols synthesised in the nervous system. In this review we discuss the biological importance of neurosterols, and how they are extracted, isolated, and analysed by GC-MS and LC-MS/MS, from brain and relevant body fluids. We present applications of methodology employed for analysis of specific sterols and comment on the relative merits of the methods employed. Finally, the importance of future in-depth "sterolomic" investigations of brain is highlighted. (C) 2009 Published by Elsevier B.V.
引用
收藏
页码:2778 / 2805
页数:28
相关论文
共 125 条
[1]   STRONG NON-POLAR CATION EXCHANGERS FOR THE SEPARATION OF STEROIDS IN MIXED CHROMATOGRAPHIC SYSTEMS [J].
AXELSON, M ;
SJOVALL, J .
JOURNAL OF CHROMATOGRAPHY, 1979, 186 (DEC) :725-732
[2]  
AXELSON M, 1988, J LIPID RES, V29, P629
[3]   Transport of side-chain oxidized oxysterols in the human circulation [J].
Babiker, A ;
Diczfalusy, U .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1998, 1392 (2-3) :333-339
[4]  
Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31
[5]   Small molecule oxidation products trigger disease-associated protein misfolding [J].
Bieschke, Jan ;
Zhang, Qinghai ;
Bosco, Daryl A. ;
Lerner, Richard A. ;
Powers, Evan T. ;
Wentworth, Paul, Jr. ;
Kelly, Jeffery W. .
ACCOUNTS OF CHEMICAL RESEARCH, 2006, 39 (09) :611-619
[6]   Crossing the barrier:: oxysterols as cholesterol transporters and metabolic modulators in the brain [J].
Bjorkhem, I. .
JOURNAL OF INTERNAL MEDICINE, 2006, 260 (06) :493-508
[7]   SERUM-CHOLESTEROL DETERMINATION BY MASS FRAGMENTOGRAPHY [J].
BJORKHEM, I ;
BLOMSTRAND, R ;
SVENSSON, L .
CLINICA CHIMICA ACTA, 1974, 54 (02) :185-193
[8]  
Björkhem I, 1998, J LIPID RES, V39, P1594
[9]   Importance of a novel oxidative mechanism for elimination of brain cholesterol - Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with O-18(2) techniques in vivo and in vitro [J].
Bjorkhem, I ;
Lutjohann, D ;
Breuer, O ;
Sakinis, A ;
Wennmalm, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30178-30184
[10]   Are side-chain oxidized oxysterols regulators also in vivo? [J].
Bjorkhem, Ingemar .
JOURNAL OF LIPID RESEARCH, 2009, 50 :S213-S218